Our Approach
We leverage our small molecule and oligonucleotide platforms to identify drug candidates with clinically validated targets and pharmacologically optimized characteristics.
Meet the Aligos TeamAligos has brought together a group of remarkable individuals with years of experience and expertise.
Meet the Aligos Team
Aligos has brought together a group of remarkable individuals with years of experience and expertise.
Scientific Overview
We are engaged in the discovery and development of purpose-built, potentially best-in-class small molecule and oligonucleotide drug candidates that target clinically validated mechanisms of action in MASH and viral diseases